Royal Bank of Canada’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-10
| Closed | -$1K | – | 7491 |
|
|
2020
Q3 | $1K | Sell |
10
-9
| -47% | -$555 | ﹤0.01% | 6552 |
|
|
2020
Q2 | $2K | Buy |
19
+3
| +19% | +$174 | ﹤0.01% | 6356 |
|
|
2020
Q1 | $1K | Sell |
16
-465
| -97% | -$26.5K | ﹤0.01% | 6580 |
|
|
2019
Q4 | $28K | Buy |
481
+362
| +304% | +$19.2K | ﹤0.01% | 5723 |
|
|
2019
Q3 | $6K | Buy |
+119
| New | +$6.93K | ﹤0.01% | 5995 |
|
|
2019
Q2 | – | Sell |
-67
| Closed | -$4K | – | 7358 |
|
|
2019
Q1 | $4K | Buy |
67
+16
| +31% | +$1.06K | ﹤0.01% | 6383 |
|
|
2018
Q4 | $3K | Sell |
51
-31
| -38% | -$1.85K | ﹤0.01% | 6395 |
|
|
2018
Q3 | $5K | Buy |
82
+71
| +645% | +$3.62K | ﹤0.01% | 6308 |
|
|
2018
Q2 | $0 | Buy |
+11
| New | +$473 | ﹤0.01% | 6913 |
|
|
2018
Q1 | – | Sell |
-7
| Closed | – | – | 7022 |
|
|
2017
Q4 | $0 | Sell |
7
-423
| -98% | -$19K | ﹤0.01% | 7094 |
|
|
2017
Q3 | $20K | Buy |
430
+359
| +506% | +$17.2K | ﹤0.01% | 5963 |
|
|
2017
Q2 | $4K | Sell |
71
-173
| -71% | -$9.06K | ﹤0.01% | 6144 |
|
|
2017
Q1 | $14K | Sell |
244
-24
| -9% | -$1.27K | ﹤0.01% | 5817 |
|
|
2016
Q4 | $15K | Buy |
268
+211
| +370% | +$10.1K | ﹤0.01% | 5928 |
|
|
2016
Q3 | $2K | Buy |
57
+7
| +14% | +$281 | ﹤0.01% | 6219 |
|
|
2016
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 6182 |
|
|
2016
Q1 | $2K | Sell |
50
-60
| -55% | -$2.2K | ﹤0.01% | 6159 |
|
|
2015
Q4 | $5K | Sell |
110
-204
| -65% | -$10.2K | ﹤0.01% | 6180 |
|
|
2015
Q3 | $13K | Buy |
314
+21
| +7% | +$1.13K | ﹤0.01% | 5780 |
|
|
2015
Q2 | $16K | Buy |
293
+187
| +176% | +$7.97K | ﹤0.01% | 5829 |
|
|
2015
Q1 | $4K | Buy |
106
+74
| +231% | +$2.9K | ﹤0.01% | 5813 |
|
|
2014
Q4 | $1K | Buy |
+32
| New | +$1.22K | ﹤0.01% | 6076 |
|
|
2014
Q3 | – | Sell |
-200
| Closed | -$5K | – | 6202 |
|
|
2014
Q2 | $5K | Buy |
+200
| New | +$5.21K | ﹤0.01% | 5579 |
|
Other funds holding BSTC
Royal Bank of Canada's BSTC Position: Q4 2020 in Review
Royal Bank of Canada sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 10 shares — an estimated $1K sold.
Royal Bank of Canada first reported a position in BSTC in Q2 2014 and held it in 23 quarters. The position peaked at $28K in Q4 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Royal Bank of Canada reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Royal Bank of Canada sold 10 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1K.
- Royal Bank of Canada first reported a position in BioSpecifics Technologies Corp. in Q2 2014 and held it in 23 quarters.
- Royal Bank of Canada's BioSpecifics Technologies Corp. position peaked at $28K in Q4 2019.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Royal Bank of Canada's 13F filing for Q4 2020, filed 16 Feb 2021.